Innovation in Women and Infant Healthcare

There is a tremendous need for progress in healthcare solutions devoted to women and babies, but ironically, this field has historically been underdeveloped and underfunded in terms of medical innovation. Every year, globally, more than three million babies die on the day they draw their first breaths, and 300,000 women perish in the process of delivery. We are working to drastically lower these numbers. We identified entrepreneurs who had the best new ideas, and brought them to the Institute to allow them to benefit from our resources to bring their products to market faster. Our in-residence companies are creating technology to treat some of the most common, and deadly, health problems:


Company Technology Patient Benefit
Materna Medical Working to reduce the incidence of childbirth-related injuries, and the lifelong consequences most women experience as result of vaginal delivery.

View company flyer
Our device is designed to prevent vaginal tearing and pelvic floor damage that commonly occurs during childbirth.

Marz Medical

Marz Medical is developing a technology aimed at reducing pain and recovery time for patients undergoing breast or burn reconstruction surgery. The technology will help mastectomy patients, and also individuals who suffered from burns anywhere on their body. Significantly, the technology has already received FDA approval to assist with tissue expansion needed during reconstructive surgery. One in eight women are diagnosed with cancer each year and about 100,000 women undergo mastectomy in the U.S.
Medical Cue Solving a major need in newborn monitoring and resuscitation by automatically sensing key physiologic data and making this information easily available to assist caregivers. More than one million babies die annually from birth asphyxia.

View company flyer
Improving newborn care in the labor and delivery and in the NICU. MedicalCue is committed to improving outcomes for newborns.
Dr. Fogarty

"We strive to create an environment where we can cost effectively develop technology that directly benefits patients."

– Thomas J. Fogarty, MD, Founder, FII